The Tier 4 Phenomenon: Shifting the High Cost of Drugs to Consumers
Cost shifting that employers and insurers are utilizing in regard to expensive drugs on the “fourth tier” of drug plan formularies is the focus of this report. It was found that consumers are increasingly being asked to pay a larger share of the costs of expensive, breakthrough drugs. (12 pages)
Original post by Smith, G. C., Sylvestre, G. M.
You must be logged in to post a comment.